In contrast to ASPSCR1-TFE3 fusion tRCC, other relatively common TFE3-tRCC fusion subtypes were characterized by decreased angiogenesis gene signatures. The gene discussed is TFE3; the disease is renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.